Trials / Terminated
TerminatedNCT00562731
Open-Label Study of ARD-0403 in Testosterone Deficient Men
A Phase III, Open-Label Follow-on Study for Long-Term Safety and Efficacy of Testosterone Cream, in Testosterone Deficinet Men Completing Study ARD-0403-004
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Ardana Bioscience Ltd · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Male hypogonadism, a disorder associated with testosterone deficiency, is frequently seen in clinical practice and has significant effects on patient well-being. The purpose of this study is to investigate the efficacy and safety of ARD-0403 as a testosterone replacement therapy in testosterone deficient men.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ARD-0403 | Daily transdermal ARD-0403 |
Timeline
- Start date
- 2007-10-01
- Completion
- 2008-06-01
- First posted
- 2007-11-22
- Last updated
- 2008-04-01
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00562731. Inclusion in this directory is not an endorsement.